Evidence map›Paper›PMID 32631635›Full record

ReviewTrends in immunology2020

Understanding Normal and Malignant Human Hematopoiesis Using Next-Generation Humanized Mice.

Yoriko Saito, Leonard D Shultz, Fumihiko Ishikawa

Abstract readReview
In one paragraph

Review in Trends in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Humanized mouse models in MDS.Cell death & disease · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Patient-Derived Xenograft Models for Leukemias.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Humanized mouse models for immuno-oncology research.Nature reviews. Clinical oncology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yoriko SaitoRIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, 230-0045, Japan.
Leonard D ShultzThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Fumihiko IshikawaRIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, 230-0045, Japan. Electronic address: fumihiko.ishikawa@riken.jp.

Funding

Humanized Mouse Avatars for T1DU01DK104218 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN, GREINER, DALE LESLIE · 2019 to 2023
$4.5M
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymusR01AI132963 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN, MAEHR, RENE · 2017 to 2021
$4.4M
Live imaging of SARS-CoV-2 infection in novel humanized miceR24OD026440 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN, EMERSON, CHARLES P. · 2019 to 2022
$4.2M
Humanized Mouse Avatars for T1DUC4DK104218 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN, DALEY, GEORGE Q · 2014 to 2014
$4.1M
The Role of Lung Resident Mesenchymal Stem Cells in Post-Chemotherapy Lung Metastases of Breast CancerR37CA237307 · NCI · JACKSON LABORATORY · PI Guangwen Ren · 2020 to 2026
$2.8M
NCI NIH HHS R37 CA237307NIAID NIH HHS R01 AI132963NIDDK NIH HHS U01 DK104218NIDDK NIH HHS UC4 DK104218NIH HHS R24 OD026440
6 · The paper itself

Abstract

Rodent models for human diseases contribute significantly to understanding human physiology and pathophysiology. However, given the accelerating pace of drug development, there is a crucial need for in vivo preclinical models of human biology and pathology. The humanized mouse is one tool to bridge the gap between traditional animal models and the clinic. The development of immunodeficient mouse strains with high-level engraftment of normal and diseased human immune/hematopoietic cells has made in vivo functional characterization possible. As a patient-derived xenograft (PDX) model, humanized mice functionally correlate putative mechanisms with in vivo behavior and help to reveal pathogenic mechanisms. Combined with single-cell genomics, humanized mice can facilitate functional precision medicine such as risk stratification and individually optimized therapeutic approaches.

Indexed as

HematopoiesisPrecision MedicineAnimalsDisease Models, AnimalHumanshuman hematopoiesishuman immunityhumanized mouseleukemiaxenograft

Identifiers

PMID32631635
PMCPMC7395895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.